Visualitza per autor "Rugo, Hope"
Ara mostrant els elements 1-11 d 11
-
Efficacy of Margetuximab vs Trastuzumab in Patients With Pretreated ERBB2-Positive Advanced Breast Cancer A Phase 3 Randomized Clinical Trial
Cardoso, Fatima; Cortés Castan, Javier; Musolino, Antonio; Saura Manich, Cristina; Rugo, Hope; Curigliano, Giuseppe; Im, Seock-Ah (American Medical Association, 2021-04) -
Genomic analysis of advanced breast cancer tumors from talazoparib-treated gBRCA1/2mut carriers in the ABRAZO study
Turner, Nicholas; Laird, A. Douglas; Telli, Melinda; Rugo, Hope; Mailliez, Audrey; Ettl, Johannes; Balmaña, Judith (Nature Portfolio, 2023-10-06) -
Health-related quality of life in the phase III ASCENT trial of sacituzumab govitecan versus standard chemotherapy in metastatic triple-negative breast cancer
Loibl, Sibylle; Loirat, Delphine; Tolaney, Sara M; Punie, Kevin; Antunes de Melo Oliveira, Ana Mafalda; Rugo, Hope (Elsevier, 2023-01) -
Immunotherapy for early triple negative breast cancer: research agenda for the next decade
Tarantino, Paolo; Corti, Chiara; Cortés Castan, Javier; Mittendorf, Elizabeth; Schmid, Peter; Rugo, Hope (Nature Research, 2022-02-18) -
Margetuximab Versus Trastuzumab in Patients With Previously Treated HER2-Positive Advanced Breast Cancer (SOPHIA): Final Overall Survival Results From a Randomized Phase 3 Trial
Cardoso, Fatima; Cortés Castan, Javier; Musolino, Antonio; Escriva de Romaní Muñoz, Santiago Ignacio; Saura Manich, Cristina; Rugo, Hope; Curigliano, Giuseppe; Im, Seock-Ah (American Society of Clinical Oncology, 2023-01-10) -
Oncological care organisation during COVID-19 outbreak
Onesti, Concetta Elisa; Generali, Daniele; Peeters, Marc; Zaman, Khalil; Wildiers, Hans; Cortés Castan, Javier; Rugo, Hope (BMJ, 2020-08-26) -
Real-world survival outcomes of heavily pretreated patients with refractory HR+, HER2−metastatic breast cancer receiving single-agent chemotherapy—a comparison with MONARCH 1
Dieras, Veronique; Cortés Castan, Javier; Patt, Debra; Wildiers, Hans; O’Shaughnessy, Joyce; Zamora Adelantado, Esther; Rugo, Hope (Springer, 2020-11) -
Sacituzumab Govitecan in Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer
Cortés Castan, Javier; Loirat, Delphine; Gómez Pardo, Patricia; Schmid, Peter; Rugo, Hope; Marmé, Frederik; Bardia, Aditya (American Society of Clinical Oncology, 2022-10-10) -
Safety analyses from the phase 3 ASCENT trial of sacituzumab govitecan in metastatic triple-negative breast cancer
Tolaney, Sara M; Loirat, Delphine; Punie, Kevin; Hurvitz, Sara; Cortés Castan, Javier; Rugo, Hope; Bardia, Aditya (Breast Cancer Research Foundation, 2022-08-29) -
The efficacy and safety of enzalutamide with trastuzumab in patients with HER2+ and androgen receptor-positive metastatic or locally advanced breast cancer
Cortés Castan, Javier; Provencher, Louise; Miller, Kathy; Chien, A. Jo; Rugo, Hope; Wardley, Andrew (Springer, 2021-05) -
TROPiCS-02: A Phase III study investigating sacituzumab govitecan in the treatment of HR+/HER2- metastatic breast cancer
Tolaney, Sara M; Arteaga, Carlos; Cortés Castan, Javier; Sohn, Joohyuk; Rugo, Hope; Bardia, Aditya (Future Medicine, 2020-04)